| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |